Safe-Pro USA Appoints 20+ Year Defense and Protective Equipment Industry Leader as VP of Marketing and Sales as it Expands its Ballistics Business
Businesswire· 2025-12-19 13:01
AVENTURA, Fla.--(BUSINESS WIRE)--Safe Pro Group Inc. (Nasdaq: SPAI) ("Safe Pro†or the "Company†), a developer of artificial intelligence (AI)-enabled defense and security solutions, today announced that its ballistic protective products unit, Safe-Pro USA (SPUSA), has appointed Michael Wratten as its new Vice President of Marketing and Sales. This appointment is part of broad business development and expansion initiatives currently under way as it responds to the increased domestic need for ad. ...
AM Best upgrades Arch on diversification and outperformance
ReinsuranceNe.ws· 2025-12-19 13:00
AM Best has upgraded Arch Capital Group and its subsidiaries’ ratings, citing the firm’s strong operating performance and a proven track record of delivering superior underwriting results and investment returns, even during softer market conditions.Notably, AM Best has upgraded the Long-Term Issuer Credit Ratings (Long-Term ICR) to “aa” (Superior) from “aa-” (Superior) and affirmed the Financial Strength Rating (FSR) of A+ (Superior) of Arch Reinsurance Ltd. (Arch) (Bermuda) and its strategic affiliates.The ...
Abacus Global Management Announces Transfer of Listing of its [Class A] Common Stock to the New York Stock Exchange with New Ticker Symbol “ABX”
Globenewswire· 2025-12-19 13:00
ORLANDO, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced its plans to transfer the listing of its [Class A] common stock to the New York Stock Exchange (“NYSE”) from the Nasdaq Stock Market LLC (“Nasdaq”). Abacus expects to begin trading as a NYSE listed company on or about December 30, 2025, and will commence trading under new ticker symbol “ABX”. The Company’s [Class A] com ...
Eminence Capital Sends Letter to GPK Board of Directors Seeking Immediate Reinstatement of Mike Doss as CEO
Prnewswire· 2025-12-19 13:00
Views Board's Decision to Replace Doss as Misguided, Ill-timed, and Done Without Proper Diligence Believes that Chairman Phil Martens Wields Outsized Influence over GPK's Board, has Jeopardized Shareholder Value, and Should Resign Encourages Shareholders with Similar Concerns to Voice Them Eminence to Evaluate All Options to Ensure Board Is Comprised of Individuals Who Are Committed to Protecting Shareholder Value NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Eminence Capital, LP ("Eminence"), a private investmen ...
Lars-Erik Brenøe steps down from Danske Bank’s Board of Directors
Globenewswire· 2025-12-19 13:00
Company announcement no. 57 2025 Danske Bank Bernstorffsgade 40 DK-1577 København V Tel. + 45 45 14 14 00 19 December 2025 Page 1 Lars-Erik Brenøe steps down from Danske Bank’s Board of Directors As communicated on 21 February 2025 in the notice convening the annual general meeting, Lars-Erik Brenøe will step down from the Board of Directors of Danske Bank A/S at the end of this year. After almost a decade of service, Lars-Erik Brenøe has notified the Board of his decision to step down, effective at 31 Dece ...
Amaero Receives US$3.0 Million Refractory Powder Order from Titomic
Globenewswire· 2025-12-19 13:00
MCDONALD, Tenn., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA) (OTCQB: AMROF) (“Amaero” or the “Company”), a leading U.S. domestic producer of high-value refractory and titanium alloy powders for additive and advanced manufacturing of components utilized by the defense, space, and aviation industries, is pleased to advise that it has received a Purchase Order from Titomic Limited (“Titomic”) in the amount of US$3.0 million for refractory alloy powders. The order has been received under the previous ...
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
Globenewswire· 2025-12-19 13:00
CAMBRIDGE, Mass., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that its development partner, GSK, filed a New Drug Application (NDA) resubmission to the U.S. Food and Drug Administration (FDA) for tebipenem HBr, an investigational oral carbapenem antibiotic being developed for the treatment of co ...
Glass House Brands Applauds Cannabis Reform Action
Globenewswire· 2025-12-19 13:00
LONG BEACH, Calif. and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., applauds yesterday’s cannabis reform action from the Trump administration. “The executive order to reschedule cannabis to a Schedule III classification and the authorization of a pilot program for Medicare reimbursement of the cannabis ...
PhoenixEV Announce Strategic Partnership with Power Parts
Accessnewswire· 2025-12-19 13:00
ANAHEIM, CA / ACCESS Newswire / December 19, 2025 / Phoenix Motor Inc. (OTC:PEVM) ("PhoenixEV" or the "Company"), leader in zero-emission commercial transportation, today announced a new strategic alignment with Powers Parts, a leading provider of OEM-approved electric-bus components and aftermarket service support. This alliance expands parts availability, enhances service responsiveness, and strengthens aftermarket support for customers throughout North America and Canada. ...
NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives
Globenewswire· 2025-12-19 13:00
Total national coverage footprint for PENFS increases to roughly 100 million covered livesCARMEL, Ind., Dec. 19, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced significant new medical policy coverage from a major national health insurer for Percutaneous Electrical Nerve Field Stimulation (“PENFS”). The coverage sp ...